                </a></li></ul></div><p><strong>Figure 3.  <span>CD8<sup>+</sup> T-cell responses (ELISpot IFNγ) to HIV peptides as a function of vaccination route, expressed as individual response.</span></strong></p><a id="article1.body1.sec3.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec3.sec1.fig1.caption1.p1"></a><p>Panel A, all responders (N = 68), and Panel B, responders given 3 injections (N = 44°. For each responder, the magnitude of the response against individual HIV peptides, expressed as the total spot-forming units per million peripheral blood mononuclear cells (SFU/10<sup>6</sup> PBMC), evaluated at times 1–4 corresponding to weeks 2, 6, 14 and 24.</p>
<span>THISISTHEEND
